Friday, December 13, 2013

First in-human trial of endoxifen shows promise as breast cancer treatment



Estrogen receptor α (ERα) ligand; potent antiestrogen. Metabolite of tamoxifen (Cat. No. 0999). Primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer...

No comments: